http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1209159-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49db6c9cd01576fbbb4fdd378a21595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021bf9e4fb6f327fd320976eb0b139c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d18c6cb8d2cea248087123223ffbfa
publicationDate 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1209159-B1
titleOfInvention Process of preparation of anhydrous mirtazapine crystals
abstract Methods for producing anhydrous mirtazapine crystals that are either (1) substantially free of lower alcohol insolubles or (2) substantially free of residual solvent and have an average particle diameter of from 10 to 50 mu m, are provided, and the resulting anhydrous mirtazapine crystals produced thereby, which are useful in pharmaceuticals.
priorityDate 2000-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129237076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227547528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10221435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128988724

Total number of triples: 23.